Dr. Jonathan M. Soh, M.D.
Mohs Surgery (MOHS-Micrographic Surgery Physician)
- Medicare participating
At a glance
- Years since graduation
- 10
- In the NPI registry since
- 2016
- Medicare patients seen, 2024
- 218
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2016Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
MOHS-Micrographic Surgery Physician primary
NY license 290940 -
Dermatology Physician
NY license 290940
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Rochester General Hospital Rochester, NY
Medical groups
- Rochester General Hospital (1,182 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 218
- Services billed
- 1,076
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 378 | 84 |
| Established patient office or other outpatient visit, 20-29 minutes | 158 | 135 |
| Destruction of precancer skin growth, 1 growth | 113 | 98 |
| Biopsy of related skin growth, first growth | 99 | 92 |
| New patient office or other outpatient visit, 30-44 minutes | 62 | 62 |
| Biopsy of related skin growth, each additional growth | 55 | 38 |
| Established patient office or other outpatient visit, 10-19 minutes | 29 | 22 |
| New patient office or other outpatient visit, 45-59 minutes | 24 | 24 |
| Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 21 | 19 |
| Destruction of skin growth, 1-14 growths | 18 | 16 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 14 payments worth $1,016 in total to this clinician.
| Genzyme Corporation | $277 |
|---|---|
| AbbVie Inc. | $210 |
| Incyte Corporation | $140 |
| Novartis Pharmaceuticals Corporation | $139 |
| Organon LLC | $125 |
| Sanofi-aventis U.S. LLC | $72.00 |
| UCB, Inc. | $36.39 |
| Cipher Pharmaceuticals US LLC | $16.87 |
| Food and Beverage | $935 |
|---|---|
| Education | $81.65 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Sanofi-aventis U.S. LLC Nov 19, 2025 | Education DUPIXENT · Immunology · in-kind | $72.00 |
| AbbVie Inc. Feb 19, 2025 | Education SKYRIZI · IMMUNOLOGY · in-kind | $9.65 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.